Acute myelogeneous leukemia (M0/M1) with novel chromosomal Abnormality of t (14; 17)(q32; q11. 2)

F Ahmad, R Dalvi, S Mandava… - American journal of …, 2007 - Wiley Online Library
Abstract Acute Myelogeneous Leukemia (AML) is a heterogeneous disease with respect to
morphology, immunophenotype, and genetic rearrangements. Multiple recurrent …

[PDF][PDF] Acute Myelogeneous Leukemia (M0/M1) With Novel Chromosomal Abnormality of t (14; 17)(q32; q11. 2)

F Ahmad, R Dalvi, S Mandava, BR Das - American Journal of …, 2007 - academia.edu
The association of cytogenetic abnormalities with AML is well established. By identifying
precise break points loci associated with abnormalities like inversions, deletions, and …

[引用][C] Acute myelogeneous leukemia (M0/M1) with novel chromosomal abnormality of t (14; 17)(q32; q11. 2)

F AHMAD, R DALVI, S MANDAVA… - American journal of …, 2007 - pascal-francis.inist.fr
Acute myelogeneous leukemia (M0/M1) with novel chromosomal abnormality of t(14;17) (q32;
q11.2) CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Acute Myelogeneous Leukemia (M0/M1) with novel chromosomal abnormality of t (14; 17)(q32; q11. 2)

F Ahmad, R Dalvi, S Mandava… - American journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
Acute Myelogeneous Leukemia (AML) is a heterogeneous disease with respect to
morphology, immunophenotype, and genetic rearrangements. Multiple recurrent …

Acute Myelogeneous Leukemia (M0/M1) with novel chromosomal abnormality of t (14; 17)(q32; q11. 2).

F Ahmad, R Dalvi, S Mandava… - American Journal of …, 2007 - europepmc.org
Acute Myelogeneous Leukemia (AML) is a heterogeneous disease with respect to
morphology, immunophenotype, and genetic rearrangements. Multiple recurrent …

[引用][C] Acute myelogeneous leukemia (M0/M1) with novel chromosomal abnormality of t (14; 17)(q32; q11. 2)

F AHMAD, R DALVI, S MANDAVA… - American journal of …, 2007 - Wiley-Liss